XML 56 R45.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED INVESTMENT PRODUCTS - Statement of Cash Flows (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Condensed Cash Flow Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities $ 632.9 $ 637.3
Net cash provided by (used in) investing activities (47.8) (8.6)
Net cash provided by (used in) financing activities (411.4) (267.8)
Effect of exchange rate changes on cash and cash equivalents of consolidated investment products 0.9 (0.8)
Net change in cash and cash equivalents during period 174.6 360.1
Cash and cash equivalents at beginning of period, including $63.1 million at December 31, 2024, and $77.2 million at December 31, 2023, held by consolidated investment products 2,712.9 2,143.8
Cash and cash equivalents at end of period, including $50.8 million at March 31, 2025, and $87.4 million at March 31, 2024, held by consolidated investment products 2,887.5 2,503.9
Consolidated T. Rowe Price investment products    
Condensed Cash Flow Statements, Captions [Line Items]    
Cash and cash equivalents at beginning of period, including $63.1 million at December 31, 2024, and $77.2 million at December 31, 2023, held by consolidated investment products 63.1 77.2
Cash and cash equivalents at end of period, including $50.8 million at March 31, 2025, and $87.4 million at March 31, 2024, held by consolidated investment products 50.8 87.4
Reportable entities | Consolidated T. Rowe Price investment products    
Condensed Cash Flow Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities (137.1) (95.7)
Net cash provided by (used in) investing activities 3.7 (0.1)
Net cash provided by (used in) financing activities 120.2 106.8
Effect of exchange rate changes on cash and cash equivalents of consolidated investment products 0.9 (0.8)
Net change in cash and cash equivalents during period (12.3) 10.2
Cash and cash equivalents at beginning of period, including $63.1 million at December 31, 2024, and $77.2 million at December 31, 2023, held by consolidated investment products 63.1 77.2
Cash and cash equivalents at end of period, including $50.8 million at March 31, 2025, and $87.4 million at March 31, 2024, held by consolidated investment products 50.8 87.4
Reportable entities | Voting interest entities    
Condensed Cash Flow Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities (79.6) (61.8)
Net cash provided by (used in) investing activities 0.7 0.0
Net cash provided by (used in) financing activities 72.1 72.7
Effect of exchange rate changes on cash and cash equivalents of consolidated investment products 0.0 0.0
Net change in cash and cash equivalents during period (6.8) 10.9
Cash and cash equivalents at beginning of period, including $63.1 million at December 31, 2024, and $77.2 million at December 31, 2023, held by consolidated investment products 7.2 25.7
Cash and cash equivalents at end of period, including $50.8 million at March 31, 2025, and $87.4 million at March 31, 2024, held by consolidated investment products 0.4 36.6
Reportable entities | Variable interest entities    
Condensed Cash Flow Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities (57.5) (33.9)
Net cash provided by (used in) investing activities 3.0 (0.1)
Net cash provided by (used in) financing activities 48.1 34.1
Effect of exchange rate changes on cash and cash equivalents of consolidated investment products 0.9 (0.8)
Net change in cash and cash equivalents during period (5.5) (0.7)
Cash and cash equivalents at beginning of period, including $63.1 million at December 31, 2024, and $77.2 million at December 31, 2023, held by consolidated investment products 55.9 51.5
Cash and cash equivalents at end of period, including $50.8 million at March 31, 2025, and $87.4 million at March 31, 2024, held by consolidated investment products $ 50.4 $ 50.8